CBT-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors

Conditions:   Solid Tumor;   Advanced Cancer;   ColoRectal Cancer;   Endometrial Cancer;   Gastric Cancer;   Hepatocellular Cancer;   Nonsmall Cell Lung Cancer;   Mesothelioma;   Ovarian Cancer;   Renal Cancer;   Nasopharyngeal Cancer;   Esophageal Cancer;   Gastroesophageal Junction Adenocarcinoma
Intervention:   Drug: Genolimzumab injection
Sponsors:   CBT Pharmaceuticals, Inc.;   Novotech (Australia) Pty Limited
Not yet recruiting - verified February 2017

http://ift.tt/2lhqu2R